Complete Filing Data
BioXcel Therapeutics, Inc. reported Stockholders Equity of -$95.46 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioXcel Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$69.9M | -$59.6M | -$179.1M | -$165.8M | -$106.9M | -$82.2M | -$33.0M | -$19.3M | -$4.5M |
| Revenue * | $642.0K | $2.3M | $1.4M | $375.0K | |||||
| Research And Development Expense | $30.3M | $30.4M | $84.3M | $91.2M | $52.7M | $58.0M | $25.8M | $14.6M | $2.7M |
| Operating Income Loss | -$50.5M | -$67.2M | -$171.8M | -$159.6M | -$106.9M | -$82.3M | -$33.6M | -$20.0M | -$4.5M |
| Operating Expenses | $106.9M | $82.3M | $33.6M | $20.0M | $4.5M | ||||
| General And Administrative Expense | $54.2M | $24.3M | $7.8M | $5.4M | $1.8M | ||||
| Selling General And Administrative Expense | $20.5M | $34.5M | $83.4M | $68.8M | $54.2M | ||||
| Interest Expense | $13.3M | $8.2M | $40.0K | $27.0K | $20.0K | ||||
| Cost Of Goods And Services Sold | $164.0K | $2.1M | $1.3M | $20.0K | |||||
| Other Nonoperating Income Expense | -$3.5M | $20.2M | $394.0K | -$427.0K | |||||
| Interest Income Expense Nonoperating Net | $633.0K | $692.0K | -$2.0K | ||||||
| Restructuring Charges | $194.0K | $2.4M | $4.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$30.9M | -$19.2M | -$7.3M | -$13.7M | -$8.3M | -$26.8M | -$50.5M | -$53.5M | -$52.8M | -$41.8M | -$37.7M | -$31.5M | -$26.8M | -$27.6M | -$26.4M | -$24.8M | -$21.4M | -$14.9M | -$9.0M | -$8.5M | -$7.2M | -$4.9M | -$3.0M | -$4.3M | -$917.0K | -$565.0K | -$529.0K | |
| Revenue * | $98.0K | $120.0K | $168.0K | $214.0K | $1.1M | $582.0K | $341.0K | $457.0K | $206.0K | $137.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Research And Development Expense | $8.7M | $10.3M | $4.6M | $5.1M | $8.0M | $11.4M | $19.6M | $27.0M | $27.8M | $22.1M | $17.9M | $18.6M | $11.9M | $13.5M | $14.7M | $16.3M | $17.9M | $12.4M | $7.1M | $6.5M | $5.7M | $3.8M | $1.8M | $2.9M | $619.0K | $324.0K | $321.0K | |
| Operating Income Loss | -$14.2M | -$15.9M | -$10.1M | -$15.3M | -$17.3M | -$24.2M | -$48.3M | -$52.4M | -$51.2M | -$39.0M | -$36.3M | -$31.5M | -$26.8M | -$27.6M | -$26.4M | -$24.8M | -$21.4M | -$15.0M | -$9.1M | -$8.6M | -$7.4M | -$5.1M | -$3.2M | -$4.3M | -$917.0K | -$565.0K | -$529.0K | |
| Operating Expenses | $36.3M | $31.5M | $26.8M | $27.6M | $26.4M | $24.8M | $21.4M | $15.0M | $9.1M | $8.6M | $7.4M | $5.1M | $3.2M | $4.3M | $917.0K | $565.0K | ||||||||||||
| General And Administrative Expense | $12.9M | $14.9M | $14.1M | $11.6M | $8.5M | $3.5M | $2.6M | $2.0M | $2.1M | $1.7M | $1.3M | $1.5M | $1.3M | $298.0K | $241.0K | $208.0K | ||||||||||||
| Selling General And Administrative Expense | $5.4M | $5.6M | $5.7M | $7.7M | $9.5M | $13.3M | $24.3M | $25.9M | $23.6M | $17.1M | $18.4M | $12.9M | $14.9M | $14.1M | ||||||||||||||
| Interest Expense | $3.6M | $3.3M | $3.3M | $3.4M | $3.7M | $1.6M | $7.0K | $11.0K | $16.0K | $7.0K | $5.0K | $12.0K | $6.0K | $18.0K | ||||||||||||||
| Cost Of Goods And Services Sold | $11.0K | $107.0K | $14.0K | $1.2M | $62.0K | $80.0K | $512.0K | $26.0K | $9.0K | $11.0K | ||||||||||||||||||
| Other Nonoperating Income Expense | -$12.5M | $657.0K | $6.6M | $4.8M | $12.0M | $32.0K | -$5.0K | $537.0K | -$246.0K | $62.0K | ||||||||||||||||||
| Interest Income Expense Nonoperating Net | -$2.9M | $1.0K | $16.0K | $85.0K | $116.0K | $164.0K | $215.0K | $232.0K | $218.0K | $4.0K | ||||||||||||||||||
| Restructuring Charges | $194.0K | $0.00 | $33.0K | $1.6M | $856.0K | $4.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$95.5M | -$93.1M | -$56.5M | $76.8M | $221.7M | $206.7M | $26.9M | $38.9M | -$982.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $28.8M | $29.9M | $65.2M | $193.7M | $233.0M | $213.1M | $32.4M | $42.6M | $887.0K |
| Cash And Cash Equivalents At Carrying Value | $28.4M | $29.9M | $65.2M | $193.7M | $233.0M | $213.1M | $32.4M | $42.6M | $887.0K |
| Retained Earnings Accumulated Deficit | -$720.1M | -$650.2M | -$590.6M | -$411.5M | -$245.8M | -$138.9M | -$56.7M | -$23.7M | -$4.5M |
| Property Plant And Equipment Net | $175.0K | $475.0K | $784.0K | $1.1M | $1.3M | $1.3M | $1.0M | $327.0K | $4.0K |
| Prepaid Expense And Other Assets Current | $4.0M | $5.3M | $2.8M | $3.1M | $2.9M | $3.0M | $1.7M | $491.0K | $3.0K |
| Liabilities Current | $53.9M | $22.2M | $27.3M | $32.9M | $16.7M | $11.8M | $8.5M | $4.7M | $2.3M |
| Liabilities And Stockholders Equity | $44.9M | $38.3M | $73.7M | $205.9M | $239.4M | $219.9M | $36.4M | $43.5M | $1.4M |
| Liabilities | $140.4M | $131.4M | $130.2M | $129.1M | $17.8M | $13.2M | $9.5M | $4.7M | $2.3M |
| Common Stock Value | $76.0K | $49.0K | $30.0K | $28.0K | $28.0K | $24.0K | $18.0K | $16.0K | $10.0K |
| Assets Current | $44.7M | $37.4M | $72.1M | $202.9M | $236.8M | $217.1M | $34.1M | $43.2M | $890.0K |
| Assets | $44.9M | $38.3M | $73.7M | $205.9M | $239.4M | $219.9M | $36.4M | $43.5M | $1.4M |
| Accrued Liabilities Current | $4.3M | $5.8M | $12.4M | $18.7M | $11.5M | $7.5M | $3.1M | $3.1M | $1.0M |
| Accounts Payable Current | $14.7M | $16.0M | $13.7M | $10.2M | $4.7M | $4.0M | $5.0M | $1.6M | $444.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.1M | -$35.4M | -$128.5M | -$39.2M | $19.8M | $180.7M | -$10.1M | $41.7M | $887.0K |
| Other Assets Noncurrent | $0.00 | $87.0K | $87.0K | $925.0K | $86.0K | $87.0K | $51.0K | $51.0K | |
| Operating Lease Right Of Use Asset | $56.0K | $382.0K | $688.0K | $976.0K | $1.2M | $1.5M | $1.2M | ||
| Operating Lease Liability Noncurrent | $0.00 | $65.0K | $440.0K | $786.0K | $1.1M | $1.4M | $1.0M | ||
| Other Liabilities Current | $293.0K | $237.0K | $331.0K | ||||||
| Other Assets Current | $10.9M | $1.4M | $2.1M | $3.8M | $956.0K | $984.0K | |||
| Inventory Net | $722.0K | $679.0K | $2.0M | $2.0M | |||||
| Long Term Debt Noncurrent | $84.7M | $102.5M | $100.6M | $93.1M | |||||
| Derivative Liabilities Noncurrent | $1.8M | $6.6M | $1.9M | $2.3M | |||||
| Receivables Net Current | $233.0K | $131.0K | $71.0K | $248.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$88.9M | -$107.7M | -$90.2M | -$85.6M | -$74.3M | -$72.4M | -$40.6M | $5.9M | $53.0M | $127.0M | $164.3M | $194.0M | $245.6M | $267.4M | $186.7M | $220.9M | $53.4M | $72.6M | $34.4M | $25.2M | $32.4M | $45.8M | $49.8M | $52.1M | -$982.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $37.3M | $18.6M | $31.0M | $40.4M | $56.3M | $74.1M | $90.0M | $127.5M | $165.5M | $232.3M | $233.5M | $200.4M | $252.9M | $273.1M | $194.0M | $233.4M | $65.5M | $80.1M | $40.3M | $30.0M | $36.3M | $47.1M | $50.3M | $55.5M | $754.0K | $285.0K | $0.00 | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $36.2M | $17.4M | $31.0M | $40.4M | $56.3M | $74.1M | $90.0M | $127.5M | $165.5M | $232.3M | $233.5M | $200.4M | $252.9M | $273.1M | $194.0M | $233.4M | $65.5M | $80.1M | $40.3M | $30.0M | $36.3M | $47.1M | $50.3M | $55.5M | ||||||
| Retained Earnings Accumulated Deficit | -$707.5M | -$676.6M | -$657.5M | -$639.3M | -$625.7M | -$617.4M | -$568.3M | -$517.9M | -$464.3M | -$356.7M | -$314.9M | -$277.3M | -$219.7M | -$192.9M | -$165.2M | -$117.8M | -$93.0M | -$71.6M | -$48.4M | -$39.4M | -$30.9M | -$16.6M | -$11.8M | -$8.7M | ||||||
| Property Plant And Equipment Net | $249.0K | $324.0K | $399.0K | $552.0K | $629.0K | $706.0K | $862.0K | $941.0K | $1.0M | $1.2M | $1.3M | $1.3M | $1.3M | $1.4M | $1.5M | $944.0K | $997.0K | $1.0M | $1.1M | $1.1M | $905.0K | $177.0K | $122.0K | $4.0K | ||||||
| Prepaid Expense And Other Assets Current | $5.7M | $5.2M | $4.7M | $4.5M | $2.8M | $2.1M | $3.9M | $3.7M | $4.5M | $5.5M | $8.4M | $5.0M | $4.0M | $3.6M | $2.8M | $2.7M | $2.8M | $3.5M | $1.1M | $1.5M | $1.8M | $467.0K | $669.0K | $808.0K | ||||||
| Liabilities Current | $37.8M | $33.4M | $25.5M | $25.6M | $27.3M | $31.5M | $39.4M | $34.7M | $28.8M | $23.4M | $20.0M | $16.0M | $14.6M | $12.4M | $12.3M | $16.3M | $16.2M | $12.3M | $8.2M | $8.0M | $6.8M | $2.0M | $1.4M | $4.2M | ||||||
| Liabilities And Stockholders Equity | $44.8M | $25.8M | $38.6M | $48.9M | $65.4M | $82.3M | $100.4M | $140.1M | $180.1M | $244.8M | $248.2M | $211.0M | $261.3M | $281.1M | $200.4M | $238.7M | $70.5M | $85.8M | $43.7M | $34.3M | $40.3M | $47.9M | $51.2M | $56.3M | ||||||
| Liabilities | $133.7M | $133.5M | $128.7M | $134.5M | $139.7M | $154.7M | $141.1M | $134.2M | $127.1M | $117.8M | $84.0M | $17.0M | $15.8M | $13.7M | $13.7M | $17.8M | $17.1M | $13.2M | $9.3M | $9.1M | $8.0M | $2.0M | $1.4M | $4.2M | ||||||
| Common Stock Value | $73.0K | $60.0K | $59.0K | $42.0K | $40.0K | $34.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $25.0K | $24.0K | $20.0K | $20.0K | $18.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | ||||||
| Assets Current | $44.4M | $25.2M | $37.8M | $47.8M | $64.2M | $80.9M | $98.7M | $138.2M | $177.3M | $241.7M | $244.9M | $207.6M | $256.9M | $276.7M | $196.8M | $236.1M | $68.3M | $83.6M | $41.4M | $31.5M | $38.1M | $47.6M | $51.1M | $56.3M | ||||||
| Assets | $44.8M | $25.8M | $38.6M | $48.9M | $65.4M | $82.3M | $100.4M | $140.1M | $180.1M | $244.8M | $248.2M | $211.0M | $261.3M | $281.1M | $200.4M | $238.7M | $70.5M | $85.8M | $43.7M | $34.3M | $40.3M | $47.9M | $51.2M | $56.3M | ||||||
| Accrued Liabilities Current | $4.4M | $5.1M | $4.0M | $10.2M | $13.5M | $13.7M | $26.6M | $19.1M | $17.1M | $13.9M | $13.4M | $10.6M | $10.7M | $9.6M | $6.5M | $6.9M | $4.5M | $3.6M | $3.4M | $3.4M | $3.3M | $830.0K | $500.0K | $267.0K | ||||||
| Accounts Payable Current | $16.3M | $16.7M | $15.5M | $14.9M | $13.3M | $17.2M | $10.7M | $11.2M | $7.7M | $5.9M | $6.0M | $5.1M | $3.4M | $2.5M | $5.3M | $8.6M | $10.4M | $6.7M | $4.2M | $4.0M | $2.1M | $1.2M | $889.0K | $3.9M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.2M | $8.9M | -$28.2M | -$32.5M | -$19.1M | $47.7M | -$6.3M | $54.6M | ||||||||||||||||||||||
| Other Assets Noncurrent | $0.00 | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $925.0K | $925.0K | $925.0K | $965.0K | $1.8M | $1.6M | $633.0K | $86.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | |||||||||
| Operating Lease Right Of Use Asset | $140.0K | $222.0K | $303.0K | $461.0K | $538.0K | $613.0K | $762.0K | $834.0K | $906.0K | $1.0M | $1.1M | $1.2M | $1.3M | $1.4M | $1.4M | $1.6M | $1.1M | $1.2M | $1.2M | $1.2M | $1.3M | |||||||||
| Operating Lease Liability Noncurrent | $0.00 | $161.0K | $256.0K | $350.0K | $529.0K | $617.0K | $703.0K | $868.0K | $949.0K | $1.0M | $1.2M | $1.3M | $1.3M | $1.5M | $907.0K | $961.0K | $1.1M | $1.1M | $1.2M | |||||||||||
| Other Liabilities Current | $832.0K | $453.0K | $484.0K | $404.0K | $392.0K | $306.0K | $299.0K | $287.0K | $281.0K | $275.0K | $678.0K | $1.1M | $1.9M | $522.0K | $659.0K | $939.0K | ||||||||||||||
| Other Assets Current | $934.0K | $995.0K | $1.4M | $1.4M | $1.6M | $1.9M | $2.2M | $4.6M | $5.0M | $2.4M | $1.7M | $1.5M | ||||||||||||||||||
| Inventory Net | $459.0K | $506.0K | $642.0K | $1.5M | $2.7M | $2.4M | $2.0M | $1.9M | $2.0M | $1.4M | $1.4M | $682.0K | ||||||||||||||||||
| Long Term Debt Noncurrent | $92.3M | $97.5M | $99.9M | $104.4M | $103.0M | $101.6M | $99.1M | $96.8M | $95.1M | $91.7M | $61.1M | |||||||||||||||||||
| Derivative Liabilities Noncurrent | $3.6M | $2.6M | $3.3M | $4.4M | $9.2M | $21.2M | $2.0M | $2.0M | $2.6M | $1.9M | $2.0M | |||||||||||||||||||
| Receivables Net Current | $0.00 | $17.0K | $3.0K | $812.0K | $378.0K | $735.0K | $431.0K | $283.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $27.0M | $101.0M | $255.8M | $17.8M | $56.5M | $2.1M | |||
| Payments Of Stock Issuance Costs | $1.6M | $474.0K | $811.0K | $3.5M | $17.8M | $2.0M | $5.9M | ||
| Share Based Compensation | $2.8M | $6.2M | $18.6M | $17.3M | $19.5M | $14.6M | $3.1M | $3.1M | $1.6M |
| Net Cash Provided By Used In Operating Activities | -$57.6M | -$72.0M | -$155.0M | -$135.3M | -$82.2M | -$66.4M | -$27.1M | -$13.5M | -$2.2M |
| Net Cash Provided By Used In Financing Activities | $56.5M | $36.7M | $26.5M | $96.2M | $102.4M | $247.4M | $17.8M | $55.5M | $3.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.2M | $1.9M | -$2.9M | $3.9M | -$103.0K | $2.3M | $1.2M | $539.0K | $1.0K |
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | -$20.0K | -$139.0K | -$445.0K | -$316.0K | -$870.0K | -$340.0K | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $20.0K | $139.0K | $445.0K | $316.0K | $870.0K | $340.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.9M | $3.2M | $3.8M | $3.2M | $737.0K | ||||
| Depreciation Depletion And Amortization | $297.0K | $188.0K | $156.0K | $17.0K | $1.0K | ||||
| Proceeds From Stock Options Exercised | $508.0K | $283.0K | $1.5M | $598.0K | $22.0K | ||||
| Increase Decrease In Operating Lease Liability | -$374.0K | -$346.0K | -$319.0K | -$293.0K | -$237.0K | -$164.0K | |||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $7.0M | -$4.3M | -$3.2M | $13.0M | $4.9M | ||||
| Increase Decrease In Inventories | $43.0K | -$1.3M | $6.0K | $2.0M | |||||
| Increase Decrease In Interest Payable Net | $0.00 | -$736.0K | $2.5M | $3.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $24.7M | $68.8M | $56.5M | $2.0M | |||||||||||
| Payments Of Stock Issuance Costs | $803.0K | $117.0K | $739.0K | $3.5M | $13.0M | $4.8M | $2.0M | $11.0K | $5.9M | $5.9M | |||||
| Share Based Compensation | $180.0K | $3.4M | $4.9M | $3.8M | $5.6M | $776.0K | $682.0K | $1.3M | $107.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$12.0M | -$17.7M | -$52.4M | -$32.4M | -$19.6M | -$12.2M | -$5.7M | -$1.0M | -$431.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $13.2M | $26.6M | $24.1M | $852.0K | $59.8M | $1.0K | $55.6M | $431.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$608.0K | -$901.0K | $2.0M | $3.5M | -$703.0K | $1.8M | $1.3M | $805.0K | |||||||
| Net Cash Provided By Used In Investing Activities | -$120.0K | -$316.0K | -$16.0K | -$600.0K | |||||||||||
| Payments To Acquire Property Plant And Equipment | $120.0K | $316.0K | $16.0K | $600.0K | |||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$676.0K | $403.0K | $3.8M | $1.6M | $1.7M | -$11.0K | |||||||||
| Depreciation Depletion And Amortization | $77.0K | $76.0K | $80.0K | $65.0K | $47.0K | $47.0K | $47.0K | $37.0K | $1.0K | ||||||
| Proceeds From Stock Options Exercised | $258.0K | $852.0K | $39.0K | $1.0K | |||||||||||
| Increase Decrease In Operating Lease Liability | -$90.0K | -$83.0K | -$77.0K | -$71.0K | |||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$2.3M | $4.8M | -$4.7M | -$676.0K | |||||||||||
| Increase Decrease In Inventories | -$37.0K | $448.0K | -$33.0K | $682.0K | |||||||||||
| Increase Decrease In Interest Payable Net | -$619.0K | $1.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.73 | -$23.51 | -$98.33 | -$5.92 | -$4.05 | -$3.79 | -$2.02 | -$1.32 | -$0.47 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 22.3M | 3.1M | 1.9M | 28.1M | 28.0M | 24.4M | 18.1M | 15.7M | 9.9M |
| Common Stock Shares Issued | 22.3M | 3.1M | 1.9M | 28.1M | 28.0M | 24.4M | 18.1M | 15.7M | 9.9M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 12.2M | 2.5M | 1.8M | 28.0M | 26.4M | 21.7M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 12.2M | 2.5M | 1.8M | 28.0M | 26.4M | 21.7M | |||
| Earnings Per Share Basic | $-5.73 | $-23.51 | $-98.33 | $-5.92 | $-4.05 | $-3.79 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 21.7M | 16.3M | 14.6M | 9.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.18 | -$2.45 | -$1.50 | -$5.15 | -$3.30 | -$13.89 | -$1.72 | -$1.83 | -$1.84 | -$1.49 | -$1.35 | -$1.12 | -$0.96 | -$1.11 | -$1.08 | -$1.07 | -$1.06 | -$0.79 | -$0.57 | -$0.54 | -$0.46 | -$0.31 | -$0.19 | -$0.37 | -$0.10 | -$0.06 | -$0.06 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 20.0M | 6.6M | 5.5M | 42.5M | 40.4M | 33.6M | 29.3M | 29.3M | 29.1M | 28.0M | 28.0M | 28.0M | 28.0M | 28.0M | 24.6M | 24.4M | 20.4M | 20.2M | 18.0M | 15.7M | 15.7M | 15.6M | 15.6M | 15.6M | ||||
| Common Stock Shares Issued | 20.0M | 6.6M | 5.5M | 42.5M | 40.4M | 33.6M | 29.3M | 29.3M | 29.1M | 28.0M | 28.0M | 28.0M | 28.0M | 28.0M | 24.6M | 24.4M | 20.4M | 20.2M | 18.0M | 15.7M | 15.7M | 15.6M | 15.6M | 15.6M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 14.2M | 7.8M | 4.8M | 2.6M | 2.5M | 1.9M | 29.3M | 29.2M | 28.6M | 28.0M | 28.0M | 28.0M | 28.0M | 25.0M | 24.5M | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 14.2M | 7.8M | 4.8M | 2.6M | 2.5M | 1.9M | 29.3M | 29.2M | 28.6M | 28.0M | 28.0M | 28.0K | 28.0M | 25.0M | 24.5M | |||||||||||||
| Earnings Per Share Basic | $-2.18 | $-2.45 | $-1.50 | $-5.15 | $-3.30 | $-13.89 | $-1.72 | $-1.83 | $-1.84 | $-1.49 | $-1.35 | $-1.12 | $-0.96 | $-1.11 | $-1.08 | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 28.0M | 25.0M | 24.5M | 23.1M | 20.3M | 19.0M | 15.8M | 15.7M | 15.7M | 15.6M | 15.6M | 11.5M | 9.5M | 9.5M | 9.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.7M | $6.2M | $18.6M | $17.3M | $19.5M | $14.6M | $3.1M | $3.1M | |
| Additional Paid In Capital | $624.6M | $557.0M | $534.1M | $488.3M | $467.4M | $345.5M | $83.6M | $62.6M | $3.5M |
| Stock Issued During Period Value New Issues | $55.4M | $9.9M | $26.2M | $101.0M | $255.8M | $17.8M | $2.0M | ||
| Stock Issued During Period Value Stock Options Exercised | $508.0K | $283.0K | $1.5M | $598.0K | $22.0K | $7.0K | |||
| Investment Income Interest | $1.1M | $2.6M | $5.6M | $2.5M | $44.0K | $155.0K | |||
| Depreciation | $300.0K | $309.0K | $318.0K | $327.0K | $297.0K | ||||
| Costs And Expenses | $51.1M | $69.5M | $173.2M | $160.0M | $106.9M | ||||
| Amortization Of Financing Costs And Discounts | $1.7M | $467.0K | $1.4M | $860.0K | |||||
| Stock Issued During Period Shares New Issues | 3.2M | 4.0M | 2.3M | 271.8K | |||||
| Interest Paid Net | $9.7M | $8.0M | $7.6M | $2.7M | $40.0K | $27.0K | $62.0K | $1.0K | |
| Paid In Kind Interest | $5.4M | $6.5M | $1.9M | $807.0K | |||||
| Derivative Gain Loss On Derivative Net | -$3.5M | $20.2M | $438.0K | -$389.0K | |||||
| Due To Related Parties Current | $204.0K | $157.0K | |||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $0.00 | $2.5M | $200.0K | $3.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $581.0K | $1.6M | $180.0K | $1.9M | $1.1M | $3.4M | $4.0M | $6.1M | $4.9M | $4.5M | $4.5M | $3.8M | $4.9M | $6.8M | $5.6M | $5.3M | $2.0M | $776.0K | $776.0K | $1.0M | $682.0K | $889.0K | $740.0K | $1.3M | |||
| Additional Paid In Capital | $618.6M | $568.9M | $567.2M | $553.7M | $551.3M | $545.0M | $527.7M | $523.7M | $517.3M | $483.7M | $479.2M | $471.3M | $465.2M | $460.2M | $351.9M | $338.7M | $146.4M | $144.2M | $82.8M | $64.5M | $63.3M | $62.5M | $61.6M | $60.8M | |||
| Stock Issued During Period Value New Issues | $49.1M | $136.0K | $481.0K | $453.0K | $5.3M | $3.7M | $23.9M | $101.0M | $187.0M | $68.8M | $17.5M | $230.0K | $2.0M | ||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $250.0K | $258.0K | $48.0K | $185.0K | $105.0K | $497.0K | $852.0K | $21.0K | $271.0K | $39.0K | $1.0K | ||||||||||||||||
| Investment Income Interest | $236.0K | $230.0K | $279.0K | $616.0K | $671.0K | $947.0K | $1.1M | $1.6M | $2.0M | $823.0K | $204.0K | $15.0K | $12.0K | $10.0K | $10.0K | $20.0K | $28.0K | $91.0K | |||||||||
| Depreciation | $75.0K | $75.0K | $76.0K | $77.0K | $77.0K | $78.0K | $79.0K | $81.0K | $80.0K | $85.0K | $84.0K | $77.0K | $76.0K | $80.0K | |||||||||||||
| Costs And Expenses | $14.3M | $16.0M | $10.3M | $15.5M | $18.4M | $24.7M | $48.6M | $52.9M | $51.4M | $39.1M | $36.3M | $31.5M | $26.8M | $4.3M | $529.0K | ||||||||||||
| Amortization Of Financing Costs And Discounts | $441.0K | $393.0K | $350.0K | $106.0K | $96.0K | $43.0K | $377.0K | $356.0K | $333.0K | $217.0K | $321.0K | ||||||||||||||||
| Stock Issued During Period Shares New Issues | 188.0K | 283.5K | 283.5K | ||||||||||||||||||||||||
| Interest Paid Net | $3.0K | $8.0K | $2.0K | ||||||||||||||||||||||||
| Paid In Kind Interest | $2.7M | $1.2M | $398.0K | ||||||||||||||||||||||||
| Derivative Gain Loss On Derivative Net | $6.6M | $30.0K | -$231.0K | ||||||||||||||||||||||||
| Due To Related Parties Current | $730.0K | $854.0K | $380.0K | $422.0K | $269.0K | $296.0K | $56.0K | $154.0K | $106.0K | $208.0K | $64.0K | $13.0K | |||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $224.0K | $3.2M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.